INNOMED specializes in the R&D and manufacturing of implantable medical device products and interventional high-end consumables.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 7, 2022 | Series C | — | 1 | Chuanggu Capital | — | Detail |
Nov 5, 2018 | Series B | ¥20M | 2 | — | — | Detail |
Mar 26, 2017 | Series B | ¥20M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Chuanggu Capital | Yes | Series C |
Taizhou Rongjianda | — | Series B |
Shengge Investment | — | Series B |
Shanghai Qingluo Investment Management | — | Series B |